Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents: a population-based cohort study using six healthcare databases from Italy, Spain, and Norway.
Durán CE, Riefolo F, Gini R, Barbieri E, Messina D, Garcia P, Martin M, Villalobos F, Stona L, Carreras JJ, Urchueguía A, Correcher-Martínez E, Zhao J, Lupattelli A, Nordeng H, Sturkenboom M. Durán CE, et al. Among authors: riefolo f. Eur J Pediatr. 2024 Nov 13;184(1):6. doi: 10.1007/s00431-024-05864-1. Eur J Pediatr. 2024. PMID: 39535547
Brain state identification and neuromodulation to promote recovery of consciousness.
van der Lande GJM, Casas-Torremocha D, Manasanch A, Dalla Porta L, Gosseries O, Alnagger N, Barra A, Mejías JF, Panda R, Riefolo F, Thibaut A, Bonhomme V, Thirion B, Clasca F, Gorostiza P, Sanchez-Vives MV, Deco G, Laureys S, Zamora-López G, Annen J. van der Lande GJM, et al. Among authors: riefolo f. Brain Commun. 2024 Oct 11;6(5):fcae362. doi: 10.1093/braincomms/fcae362. eCollection 2024. Brain Commun. 2024. PMID: 39474045 Free PMC article. Review.
Corrigendum to "A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases" [Vaccine 42 (12) (2024) 3039-3048].
Schultze A, Martin I, Messina D, Bots S, Belitser S, Carreras-Martínez JJ, Correcher-Martinez E, Urchueguía-Fornes A, Martín-Pérez M, García-Poza P, Villalobos F, Pallejà-Millán M, Bissacco CA, Segundo E, Souverein P, Riefolo F, Durán CE, Gini R, Sturkenboom M, Klungel O, Douglas I. Schultze A, et al. Among authors: riefolo f. Vaccine. 2024 Oct 12:126438. doi: 10.1016/j.vaccine.2024.126438. Online ahead of print. Vaccine. 2024. PMID: 39396886 Free article. No abstract available.
Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study.
Luxi N, Ciccimarra F, Bellitto C, Raethke M, van Hunsel F, Lieber T, Mulder E, L'Abbate L, Marques FB, Furci F, Farcas A, Giele-Eshuis J, Morton K, Sonderlichová S, Thurin NH, Villalobos F, Riefolo F, Sturkenboom MC, Trifirò G. Luxi N, et al. Among authors: riefolo f. Vaccines (Basel). 2024 Sep 17;12(9):1059. doi: 10.3390/vaccines12091059. Vaccines (Basel). 2024. PMID: 39340089 Free PMC article.
What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European "Covid Vaccine Monitor" Active Surveillance Study.
Bellitto C, Luxi N, Ciccimarra F, L'Abbate L, Raethke M, van Hunsel F, Lieber T, Mulder E, Riefolo F, Villalobos F, Thurin NH, Marques FB, Morton K, O'Shaughnessy F, Sonderlichová S, Farcas A, Janneke GE, Sturkenboom MC, Trifirò G. Bellitto C, et al. Among authors: riefolo f. Drug Saf. 2024 Oct;47(10):1011-1023. doi: 10.1007/s40264-024-01449-x. Epub 2024 Jun 22. Drug Saf. 2024. PMID: 38907947 Free PMC article.
Photoswitchable Carbamazepine Analogs for Non-Invasive Neuroinhibition In Vivo.
Camerin L, Maleeva G, Gomila AMJ, Suárez-Pereira I, Matera C, Prischich D, Opar E, Riefolo F, Berrocoso E, Gorostiza P. Camerin L, et al. Among authors: riefolo f. Angew Chem Int Ed Engl. 2024 Sep 16;63(38):e202403636. doi: 10.1002/anie.202403636. Epub 2024 Aug 14. Angew Chem Int Ed Engl. 2024. PMID: 38887153
A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases.
Schultze A, Martin I, Messina D, Bots S, Belitser S, José Carreras-Martínez J, Correcher-Martinez E, Urchueguía-Fornes A, Martín-Pérez M, García-Poza P, Villalobos F, Pallejà-Millán M, Alberto Bissacco C, Segundo E, Souverein P, Riefolo F, Durán CE, Gini R, Sturkenboom M, Klungel O, Douglas I. Schultze A, et al. Among authors: riefolo f. Vaccine. 2024 Apr 30;42(12):3039-3048. doi: 10.1016/j.vaccine.2024.03.043. Epub 2024 Apr 5. Vaccine. 2024. PMID: 38580517 Free article.
Safety Monitoring of COVID-19 Vaccines in Persons with Prior SARS-CoV-2 Infection: A European Multi-Country Study.
Ciccimarra F, Luxi N, Bellitto C, L'Abbate L, Raethke M, van Hunsel F, Lieber T, Mulder E, Riefolo F, Dureau-Pournin C, Farcas A, Batel Marques F, Morton K, Roy D, Sonderlichová S, Thurin NH, Villalobos F, Sturkenboom MC, Trifirò G. Ciccimarra F, et al. Among authors: riefolo f. Vaccines (Basel). 2024 Feb 26;12(3):241. doi: 10.3390/vaccines12030241. Vaccines (Basel). 2024. PMID: 38543875 Free PMC article.
Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study.
Raethke M, van Hunsel F, Luxi N, Lieber T, Bellitto C, Mulder E, Ciccimarra F, Riefolo F, Thurin NH, Roy D, Morton K, Villalobos F, Batel Marques F, Farcas A, Sonderlichová S, Belitser S, Klungel O, Trifirò G, Sturkenboom MC. Raethke M, et al. Among authors: riefolo f. Vaccine. 2024 Apr 2;42(9):2357-2369. doi: 10.1016/j.vaccine.2024.03.001. Epub 2024 Mar 6. Vaccine. 2024. PMID: 38448322 Free article.
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries.
Riefolo F, Castillo-Cano B, Martín-Pérez M, Messina D, Elbers R, Brink-Kwakkel D, Villalobos F, Ingrasciotta Y, Garcia-Poza P, Swart-Polinder K, Souverein P, Saiz LC, Bissacco CA, Leache L, Tari M, Crisafulli S, Grimaldi L, Vaz T, Gini R, Klungel O, Martín-Merino E. Riefolo F, et al. Vaccine. 2023 Nov 13;41(47):7007-7018. doi: 10.1016/j.vaccine.2023.10.011. Epub 2023 Oct 17. Vaccine. 2023. PMID: 37858451 Free article.
17 results